Fractyl Health, Inc. (GUTS)
1.08
+0.11
(+11.87%)
USD |
NASDAQ |
Nov 18, 16:00
1.05
-0.03
(-2.78%)
After-Hours: 07:38
Fractyl Health Net Income (Quarterly) : -14.15M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -14.15M |
| June 30, 2026 | -25.54M |
| March 31, 2026 | 9.218M |
| December 31, 2025 | -43.73M |
| September 30, 2025 | -45.60M |
| June 30, 2025 | -27.89M |
| March 31, 2025 | -23.74M |
| December 31, 2024 | -24.97M |
| September 30, 2024 | -23.17M |
| June 30, 2024 | -17.23M |
| March 31, 2024 | -3.322M |
| Date | Value |
|---|---|
| December 31, 2023 | -19.18M |
| September 30, 2023 | -15.75M |
| June 30, 2023 | -30.23M |
| March 31, 2023 | -11.93M |
| December 31, 2022 | -10.86M |
| September 30, 2022 | -11.06M |
| December 31, 2021 | -12.53M |
| September 30, 2021 | -9.13M |
| December 31, 2020 | -8.135M |
| September 30, 2020 | -7.384M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Co-Diagnostics, Inc. | -6.306M |
| Spectral AI, Inc. | -3.656M |
| Omnicell, Inc. | 11.04M |
| Oncolytics Biotech, Inc. | -9.705M |
| Sangamo Therapeutics, Inc. | -31.00M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 14.15M |
| EPS Diluted (Quarterly) | -1.068 |
| Enterprise Value | 42.34M |
| Earnings Yield | -529.9% |
| Normalized Earnings Yield | -554.46 |